Letter to the EditorCardiac fibrosis, arrhythmia and sudden death in myotonic dystrophy type 1: Could TGF-ß1 improve the predictive accuracy of patients at risk, opening new therapeutic challenges?
References (10)
- et al.
Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder
Gene
(2013) - et al.
Cardiac manifestations of myotonic dystrophy type 1
Int J Cardiol
(2012) - et al.
Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases
J Am Coll Cardiol
(1988) - et al.
Myotonic dystrophies and the heart
Cardiol Rev
(2012) - et al.
The heart and cardiac pacing in Steinert disease
Acta Myol
(2012)
There are more references available in the full text version of this article.
Cited by (14)
Importance of three-dimensional speckle tracking in the assessment of left atrial and ventricular dysfunction in patients with myotonic dystrophy type 1
2018, Revista Portuguesa de CardiologiaCitation Excerpt :This suggests that assessment of myocardial fibrosis by cardiac magnetic resonance may be a useful tool in the assessment of these patients, since myocardial fibrosis may be the substrate for ventricular arrhythmias. Also, high levels of transforming growth factor beta 1, a sensitive marker of fibrosis, have been reported in patients with DM1, indicating a higher risk of arrhythmic events and sudden death.25 Previous studies have shown the usefulness of subclinical detection of cardiac involvement in DM1.
Sudden cardiac death in neuromuscular disorders
2016, International Journal of CardiologyMyotonic Dystrophy
2015, Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's ApproachEarly changes of myocardial deformation properties in patients with dystrophia myotonica type 1: A three-dimensional Speckle Tracking echocardiographic study
2014, International Journal of CardiologyCardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy
2023, Journal of Cardiovascular MedicineReducing the Excess Activin Signaling Rescues Muscle Degeneration in Myotonic Dystrophy Type 2 Drosophila Model
2022, Journal of Personalized Medicine
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.